P

Parambil

AI-assisted medical record review for litigation

Overview

Parambil provides AI-assisted medical record review software for complex litigation, helping law firms manage large volumes of medical evidence across cases such as medical malpractice, birth injury, nursing home negligence, mass torts, product liability, and more. The platform analyzes medical records, depositions, expert reports, and other documents to generate comprehensive medical chronologies and sortable timelines with source-linked items; it also offers an AI Case Agent for end-to-end case work, a Drafting Agent for legal documents, real-time clinical guidelines, and an Ask AI function for record questions. It differentiates itself from competitors by using AI agents and a provider guide to speed up review and improve consistency compared with manual paralegal or nurse-consultant work. Parambil’s goal is to turn medical complexity into courtroom clarity while accelerating review and improving accuracy for litigation teams.

Work here?Claim your company

About Parambil

Simplify's Rating
Why Parambil is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareAI & Machine LearningLegal

Company Size

11-50

Company Stage

Seed

Total Funding

$6M

Headquarters

New York City, New York

Founded

2023

Get referred to Parambil

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Hundreds of law firms use Parambil, plus CM Injury selected it October 2026.
  • January 14, 2026 funding and reported 5x 2026 growth provide hiring runway.
  • Vault's 2026 launch and live guideline search shorten review cycles from months to days.

What critics are saying

  • Seed-funded Parambil raised only $6 million on January 14, 2026; scaling remains fragile.
  • Wisedocs, SiftMed, and Medilenz crowd medical-record review; pricing pressure intensifies through 2027.
  • If courts reject AI chronologies after a hallucination, Parambil's credibility collapses instantly.

What makes Parambil unique

  • Parambil's October 1, 2026 CM Injury win validates litigation-specific medical AI.
  • Its February 19, 2026 agentic platform executes investigation, drafting, research, and organization end-to-end.
  • SOC 2 Type II, HIPAA compliance, and source-linked chronologies support defensible courtroom workflows.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$6M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
$2.3M
$3M
$6M

Benefits

  • Health Insurance
  • Remote Work Options
  • Stock Options
  • Company Equity

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

-10%

2 year growth

5%
PR Newswire
Oct 1st, 2026
Parambil selected by CM Injury Trial Lawyers for ai-powered medical records analysis.

Parambil selected by CM Injury Trial Lawyers for ai-powered medical records analysis. Oct 01, 2026, 12:10 ET Newly Launched Philadelphia Firm Integrates Cutting Edge Technology Into Complex Catastrophic Injury and Medical Malpractice Practice. NEW YORK, Oct. 1, 2026 /PRNewswire/ - CM Injury Trial Lawyers, a newly launched catastrophic injury and medical malpractice boutique founded by former Kline & Specter partners Frank Mangiaracina and Michael Cavaliere, has selected Parambil as its AI medical record review platform. Parambil is purpose-built for complex medical litigation that includes medical malpractice, birth injury, catastrophic injury, and wrongful death. Using Parambil, firms may rapidly review and analyze large volumes of medical records, surface standard-of-care deviations, and produce comprehensive work products without sacrificing attorney oversight. For CM Injury Trial Lawyers, the platform supports the firm's strategy of allowing its attorneys to focus on high-value legal work while the proprietary tech bolsters their already high standard of legal records review. The firm, which opened in Conshohocken, Pennsylvania in late August, was founded with the explicit goal of building a technology-enabled plaintiff practice with strengths in winning complex, high-stakes catastrophic injury and wrongful death litigation. Parambil's platform will serve as a key component in CM Injury's technology stack and a compelling advantage for their clients and partners. Frank Mangiaracina, the firm's co-founder, said the platform extends work the firm already does rather than replacing any part of it. Frank said: "We have always won these cases by reading the records ourselves, and that has not changed. Parambil does not read the file for us. It makes sure nothing in it gets past us, and the judgment stays where it has always been. The difference now is the size of a file no longer decides how much of it we read." Michael Cavaliere, the firm's co-founder, said advances in technology have changed what a practice of their size can take on. Mike commented: "We aren't pursuing technologies like Parambil to work faster. We leverage these tools so that by the time we walk into a room, we know the record better than anyone else in the case. In the cases we take, we intend to be the best-prepared lawyers in it." The firm's evaluation was led by Michael Smith, PhD, its Director of Technology, who spent twelve years at Moderna, where he led Phase I clinical manufacturing for the company's COVID-19 vaccine and scaled the process for global emergency supply. He builds and runs CM Injury's in-house evidence systems. Mike explained: "In manufacturing you cannot inspect quality into a product, you have to build it in. The same is true of a case, and of the firm around it. We had the unusual chance to design a practice rather than reform one. Parambil was built from scratch the same way, which is why it fits. You do not build an ordinary process around lawyers operating at the level these partners do." Sara Cordrey, CEO of Parambil, added: "CM Injury Trial Lawyers is building a modern law practice from scratch, with every tool on the table. They chose Parambil. That's the clearest signal we could ask for about where plaintiff firms are headed." "Frank Mangiaracina and Michael Cavaliere bring serious trial experience to every case they take on," Cordrey said. "We're honored to partner with them and support that work." About CM Injury Trial Lawyers CM Injury Trial Lawyers is a Philadelphia-area plaintiff firm focused on catastrophic personal injury, wrongful death, and medical malpractice litigation. Founded by Frank Mangiaracina and Michael Cavaliere, former partners at Kline & Specter, the firm was built from the ground up with a technology-forward approach to complex litigation. Learn more at cminjury.com. About Parambil Parambil is an AI platform purpose-built for complex medical litigation. The platform helps plaintiff firms handling medical malpractice, birth injury, nursing home neglect, catastrophic injury, and mass torts build stronger cases faster - through AI-powered medical record review, chronology building, standard-of-care analysis, and drafting. Learn more at parambil.com. SOURCE Parambil

PR Newswire
Feb 19th, 2026
Parambil launches agentic AI platform with four autonomous agents for complex litigation

Parambil has launched an agentic AI platform for complex litigation, introducing four autonomous agents that investigate, draft, research and organise cases. The New York-based startup marks a shift from chatbots to document-grounded systems that execute multi-step workflows and verify conclusions against source records. The platform includes Case Counsel for end-to-end case investigation, Quill for drafting legal documents, a Web Search Agent partnered with Perplexity for real-time access to clinical guidelines, and Vault for file organisation launching in Q2 2026. Built for medical malpractice, birth injury and mass tort litigation, the system uses technology from Anthropic, OpenAI, Perplexity and Google. Parambil serves hundreds of law firms and was founded by Sara Dwyer, Liam Gordon and Ralph Horwitz.

Law.com
Jan 13th, 2026
Parambil raises $6M seed round for AI medical record review software expansion

Parambil, an AI-powered medical record review software provider, has raised $6 million in a seed funding round led by Bling Capital. The company, which initially focused on mass torts cases, has expanded to cover personal injury cases more broadly. The startup plans to use the funding to hire engineers and further develop its platform for handling complicated medical litigation. Parambil's software uses artificial intelligence to streamline the review of medical records, a time-consuming process in legal cases. The investment reflects growing interest in legal technology solutions that apply AI to reduce costs and improve efficiency in litigation workflows.

Recently Posted Jobs

Sign up to get curated job recommendations

Parambil is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs